BrainSpace
Private Company
Total funding raised: $3.2M
Overview
BrainSpace is a private, pre-revenue medical device startup developing an automated system for managing cerebrospinal fluid (CSF) drainage in hospital settings. Their core product, the Intellidrop, aims to replace labor-intensive manual methods with a precise, automated, and data-generating platform, targeting improved clinical efficiency, patient experience, and data collection for research. The company is positioned to address a significant global need in neurocritical care, with a seasoned leadership team combining medtech commercialization, engineering, and clinical expertise.
Technology Platform
The Intellidrop platform integrates continuous CSF pressure sensing, robotic precision for drainage control, and closed-loop automation software ('Physical AI') to manage intracranial pressure. It includes a wearable transducer and generates autonomously annotated, high-frequency multimodal data for clinical use and research.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The primary competition is the entrenched standard of care: manual external ventricular drains (EVDs) and lumbar drainage systems from companies like Integra LifeSciences (external drainage and monitoring) and Medtronic. BrainSpace's automation and data features represent a disruptive approach. Other startups may be exploring smart drainage, but BrainSpace appears to have a first-mover advantage with a fully integrated system.